Kymera Therapeutics Inc (KYMR) stock has risen 33.29% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives KYMR stock a score of 54 out of a possible 100.
That rank is influenced by a long-term technical score of 90. KYMR's rank also includes a short-term technical score of 51.
KYMR has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on KYMR!
Kymera Therapeutics Inc (KYMR) stock has gained 0.63% while the S&P 500 is down -0.09% as of 11:58 AM on Wednesday, Mar 13. KYMR has risen $0.27 from the previous closing price of $41.85 on volume of 128,011 shares. Over the past year the S&P 500 has gained 31.92% while KYMR has risen 33.29%. KYMR lost -$2.52 per share in the over the last 12 months.
Click Here to get the full Stock Report for Kymera Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
